Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease
| | | |

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

On Jul. 10, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental…

NIH will reinstate 900 grants in response to court order
| | | | | | | | | | | | | | | | | | | | |

NIH will reinstate 900 grants in response to court order

On Jun. 25, 2025, the National Institutes of Health (NIH) moved to reinstate about 900 grants that a…

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
| | | | | | | | | | | | | | | | | | | | | | | | |

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published

On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…

HHS starts layoffs of thousands of workers across its agencies
| | | | | | | | | | | | | | | | | | | | |

HHS starts layoffs of thousands of workers across its agencies

On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis
| |

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis

On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…